Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Osteosarcoma × Platinum × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 10 Uterine Cervical Neoplasms 5 Small Cell Lung Carcinoma 5 Stomach Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Neuroblastoma 3 Medulloblastoma 3 Fallopian Tube Neoplasms 3 Brain Neoplasms 3 Urinary Bladder Neoplasms 2 Urethral Neoplasms 2 Ureteral Neoplasms 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Lung Neoplasms 2 Ganglioneuroblastoma 2 Gallbladder Neoplasms 2 Cholangiocarcinoma 2 Carcinoma, Hepatocellular 2 Adenocarcinoma of Lung 2 Vulvar Neoplasms 1 Triple Negative Breast Neoplasms 1 Stage II Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 1 Stage I Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 1 Sarcoma 1 Rhabdoid Tumor 1 Recurrent Uterine Corpus Carcinoma 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Pinealoma 1

Interventions

Methotrexate 15 Ifosfamide 15 Filgrastim 11 Doxorubicin 11 Etoposide 10 Cisplatin 10 Leucovorin 7 Gemcitabine 7 Cyclophosphamide 7 Sirolimus 6 Granulocyte Colony-Stimulating Factor 5 Carboplatin 5 Topotecan 4 Temozolomide 4 Sorafenib 4 Irinotecan 4 Docetaxel 4 trimetrexate glucuronate 3 temsirolimus 3 dinutuximab 3 cixutumumab 3 Radiotherapy 3 Peripheral Blood Stem Cell Transplantation 3 Nivolumab 3 Magnetic Resonance Spectroscopy 3 Imatinib Mesylate 3 tanespimycin 2 sargramostim 2 pegfilgrastim 2 mifamurtide 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00134030 2023-06-07

EURAMOS-1

Children's Oncology Group

Phase 3 Completed

1,334 enrolled 17 charts

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡